Raloxifene may infrequently cause serious blood clots to form in the legs or lungs. Tell your doctor if you have history of blood clots (e.g., deep venous thrombosis, pulmonary embolism). Also talk to your doctor about risk factors for developing strokes (sometimes fatal) while taking this medication. Some risk factors include tobacco use, alcohol use, having high cholesterol/diabetes, or history of heart disease. Discuss...
Read moreIsn't it ironic? Just a couple of years after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Q. My family history of breast cancer (both my mother and sister have had it) puts me at high risk of the disease. And now that I'm pushing... Read more »
A new study indicates that raloxifene (sold under the brand name Evista) is safe and effective for treating osteoporosis in postmenopausal... Read more »
After intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its use against breast cancer. A related... Read more »
Researchers say the drug tamoxifen prevented more cases of breast cancer after 7 years than the osteoporosis drug Evista, though Evista had fewer... Read more »
Source: Breastcancer.org
Chemical name: Evista Brand name: Raloxifene Class: SERM (selective estrogen receptor modulator) hormonal therapy. Tamoxifen and Fareston are other... Read more »
Source: Breastcancer.org
Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of... Read more »
A Food and Drug Administration (FDA) panel has recommended Evista for use in preventing breast cancer. Evista is an osteoporosis medication that has... Read more »
Doctors at the University of Minnesota have found that the osteoporosis drug Evista is safe and effective in women with mild to moderate chronic... Read more »